FERRARI RENEWS ITS PARTNERSHIP WITH PHILIP MORRIS INTERNATIONAL

12/3/25 6:19:09 AM ET

$PM

$RACE

Medicinal Chemicals and Botanical Products

Health Care

Auto Manufacturing

Industrials

Get the next $PM alert in real time by email

Maranello (Italy), December 3, 2025 – Ferrari N.V. (NYSE/EXM: RACE) ("Ferrari" or "the Company") announced today that Ferrari S.p.A., its wholly-owned Italian subsidiary, has renewed and strengthened its multi-year partnership with Philip Morris International (NYSE:PM).

Under the agreement – signed today and taking effect on January 1, 2026 – Philip Morris International becomes a Premium Partner of Scuderia Ferrari HP and a Series Partner of the Ferrari Challenge Trofeo Pirelli, continuing a collaboration that has spanned more than 50 years.

For further information:

Media Relations

tel.: +39 0536 949337

Email: [email protected]

Attachment

CS_FNV_PMI_ENG

Get the next $PM alert in real time by email

Crush Q1 2026 with the Best AI Superconnector

Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

AI-Powered Inbox

Context-aware email replies

Strategic Decision Support

Get Started with Standout.work

Recent Analyst Ratings for
$PM
$RACE

Company	Date	Price Target	Rating	Analyst
Ferrari N.V. $RACE	12/8/2025	$425.00	Overweight → Equal-Weight	Morgan Stanley
Ferrari N.V. $RACE	10/2/2025	$470.00	Hold → Buy	HSBC Securities
Ferrari N.V. $RACE	9/16/2025		Buy	Berenberg
Ferrari N.V. $RACE	9/2/2025		Hold → Buy	Deutsche Bank
Philip Morris International Inc $PM	7/9/2025	$220.00	Buy	Jefferies
Philip Morris International Inc $PM	5/22/2025	$195.00	Buy	Needham
Philip Morris International Inc $PM	4/25/2025	$170.00	Sell → Neutral	UBS
Ferrari N.V. $RACE	3/28/2025		Hold → Buy	Kepler

More analyst ratings

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

Maranello (Italy), December 9, 2025 – Ferrari N.V. (NYSE/EXM: RACE) ("Ferrari" or the "Company") informs that the Company has purchased, under the Euro 360 million share buyback program announced on July 31, 2025, as the eighth tranche of the multi-year share buyback program of approximately Euro 2 billion expected to be executed by 2026 in line with the disclosure made during the 2022 Capital Markets Day (the "Eighth Tranche"), the additional common shares - reported in aggregate form, on a daily basis - on the New York Stock Exchange (NYSE) as follows: TradingDate(dd/mm/yyyy)Stock ExchangeNumber of common shares purchasedAverage price per shareexcluding fees($)Consideration excluding fees(

12/9/25 9:19:30 AM ET

$RACE

Auto Manufacturing

Industrials

FERRARI N.V. SIGNS A NEW SYNDICATED REVOLVING CREDIT FACILITY

Maranello (Italy), 3 December 2025 – Ferrari N.V. (NYSE/EXM: RACE) ("Ferrari" or the "Company") announces that it has signed a Euro 350 million unsecured committed revolving credit facility, intended for general corporate and working capital purposes (the "New RCF"). The New RCF, entered into with a group of twelve banks, has a five-year tenor with two further one-year extension options, exercisable on the first and second anniversary of the signing date on Ferrari's request and on each bank's approval for its participation. This facility replaces the Euro 350 million committed revolving credit facility due December 2026, which has been cancelled. The New RCF provides a lower cost of capi

12/3/25 1:28:17 PM ET

$RACE

Auto Manufacturing

Industrials

FERRARI RENEWS ITS PARTNERSHIP WITH PHILIP MORRIS INTERNATIONAL

Maranello (Italy), December 3, 2025 – Ferrari N.V. (NYSE/EXM: RACE) ("Ferrari" or "the Company") announced today that Ferrari S.p.A., its wholly-owned Italian subsidiary, has renewed and strengthened its multi-year partnership with Philip Morris International (NYSE:PM). Under the agreement – signed today and taking effect on January 1, 2026 – Philip Morris International becomes a Premium Partner of Scuderia Ferrari HP and a Series Partner of the Ferrari Challenge Trofeo Pirelli, continuing a collaboration that has spanned more than 50 years. For further information:Media Relationstel.: +39 0536 949337Email: [email protected] Attachment CS_FNV_PMI_ENG

12/3/25 6:19:09 AM ET

$PM

$RACE

Medicinal Chemicals and Botanical Products

Health Care

Auto Manufacturing

Industrials

$PM
$RACE
Leadership Updates

Live Leadership Updates

View All

Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation

Pharmaceutical customers and patients to benefit from the combined design, development and manufacturing services of Vectura and Phillips Medisize Phillips Medisize to add a market-leading position in inhalation combination product development to its existing suite of drug delivery device design capabilities Vectura employees to join a large global company, dedicated to improving patients' lives through innovative products and world class quality and manufacturing capabilities Molex, a parent to Phillips Medisize, a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, announced that, through its affiliate Molex

9/17/24 9:11:00 AM ET

$PM

Medicinal Chemicals and Botanical Products

Health Care

Philip Morris International Names New External Affairs Leader

Philip Morris International Inc. (PMI) (NYSE:PM) is pleased to announce the appointment of Christos Harpantidis to the position of Senior Vice President, External Affairs effective May 1, 2024. In his new role, Mr. Harpantidis will report to the company's CEO, Jacek Olczak. "Christos is an experienced business leader with a proven track record of engaging society on the benefits of tobacco harm reduction and risk-proportionate regulation for smoke-free products," said CEO Jacek Olczak. "He has been instrumental in building our smoke-free business in Greece and the South East Europe Area as we evolve away from cigarettes. I'm looking forward to working with Christos and excited to see what

3/26/24 5:48:00 AM ET

$PM

Medicinal Chemicals and Botanical Products

Health Care

Philip Morris International's U.S. Business Champions Female Economic Growth in Connecticut with Record-Setting $5 Million Investment Through New Partnership with Women's Business Development Council

In honor of Women's History Month and in advance of International Women's Day, investment and partnership support female economic empowerment and equality through entrepreneurship Today, Philip Morris International (PMI) (NYSE:PM) announces the launch of an extended partnership via its U.S. business to support female empowerment with a record-setting $5 million investment in the Women's Business Development Council (WBDC), a 501(c)(3) charitable organization dedicated to providing tools and resources to help women entrepreneurs thrive in business throughout Connecticut. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202403048002

3/4/24 6:48:00 PM ET

$PM

Medicinal Chemicals and Botanical Products

Health Care

$PM
$RACE
Financials

Live finance-specific insights

View All

Philip Morris International Presents at 2025 Morgan Stanley Global Consumer & Retail Conference

Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) Chief Executive Officer, Jacek Olczak, will address investors today at the Morgan Stanley Global Consumer & Retail Conference. The event will be webcast live in listen-only mode here, beginning at approximately 10:15 a.m. ET, and on the PMI Investor Relations Mobile Application (www.pmi.com/irapp). An archived copy of the webcast will be available for six months after the event. 2025 Full-Year Forecast PMI reaffirms its 2025 full-year reported diluted EPS forecast, announced on October 21, 2025, of $7.39 to $7.49. Excluding a total 2025 adjustment of $0.07 per share, this forecast represents a projected increase of 13.5% t

12/2/25 7:00:00 AM ET

$PM

Medicinal Chemicals and Botanical Products

Health Care

CONSISTENT EXECUTION: STRONG Q3 2025 RESULTS

Net revenues of Euro 1,766 million, up 7.4% versus prior year, with total shipments of 3,401 unitsOperating profit (EBIT)(1) of Euro 503 million, up 7.6% versus prior year, with Operating profit (EBIT) margin of 28.4%Net profit of Euro 382 million and diluted EPS at Euro 2.14EBITDA(1) of Euro 670 million, up 5.0% versus prior year, with EBITDA margin of 37.9%Industrial free cash flow(1) generation of Euro 365 million2025 guidance revised upward during the Capital Markets Day "We continue to advance with conviction and strong visibility on our development path. At our Capital Markets Day, we have defined a clear trajectory in the long-term interests of our brand, setting the floor for sustai

11/4/25 6:22:08 AM ET

$RACE

Auto Manufacturing

Industrials

FERRARI TO ANNOUNCE THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 4

Maranello (Italy), October 21, 2025 - Ferrari N.V. ("Ferrari") (NYSE/EXM: RACE) announced today that its financial results for the third quarter of 2025 will be released on Tuesday, November 4, 2025. A live audio webcast and conference call of the 2025 Q3 results will begin at 2:00 p.m. GMT / 3:00 p.m. CET / 9:00 a.m. EST on Tuesday, November 4. Details for accessing this presentation will be available in the Investors section of Ferrari's corporate website at https://www.ferrari.com/en-EN/corporate prior to the event. Please note that registering in advance is required to access the conference call details. For those unable to participate in the live session, a replay will remain archived

10/21/25 1:21:35 PM ET

$RACE

Auto Manufacturing

Industrials

FERRARI RENEWS ITS PARTNERSHIP WITH PHILIP MORRIS INTERNATIONAL

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$PM
$RACE

FERRARI RENEWS ITS PARTNERSHIP WITH PHILIP MORRIS INTERNATIONAL

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$PM
$RACE

$PM
$RACE
SEC Filings

Philip Morris International Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

SEC Form 6-K filed by Ferrari N.V.

SEC Form 6-K filed by Ferrari N.V.

$PM
$RACE
Analyst Ratings

Ferrari downgraded by Morgan Stanley with a new price target

Ferrari upgraded by HSBC Securities with a new price target

Berenberg initiated coverage on Ferrari

$PM
$RACE
Insider Trading

New insider Trumpaitis Mindaugas claimed ownership of 73,002 shares (SEC Form 3)

Director Temperley Dessislava was granted 1,002 shares, increasing direct ownership by 15% to 7,756 units (SEC Form 4)

Director Bough Bonin was granted 1,002 shares, increasing direct ownership by 11% to 9,834 units (SEC Form 4)

$PM
$RACE
Press Releases

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

FERRARI N.V. SIGNS A NEW SYNDICATED REVOLVING CREDIT FACILITY

FERRARI RENEWS ITS PARTNERSHIP WITH PHILIP MORRIS INTERNATIONAL

$PM
$RACE
Leadership Updates

Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation

Philip Morris International Names New External Affairs Leader

Philip Morris International's U.S. Business Champions Female Economic Growth in Connecticut with Record-Setting $5 Million Investment Through New Partnership with Women's Business Development Council

$PM
$RACE
Financials

Philip Morris International Presents at 2025 Morgan Stanley Global Consumer & Retail Conference

CONSISTENT EXECUTION: STRONG Q3 2025 RESULTS

FERRARI TO ANNOUNCE THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 4

$PM
$RACE
Large Ownership Changes

SEC Form SC 13G/A filed by Ferrari N.V. (Amendment)

SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

FERRARI RENEWS ITS PARTNERSHIP WITH PHILIP MORRIS INTERNATIONAL

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $PM$RACE

FERRARI RENEWS ITS PARTNERSHIP WITH PHILIP MORRIS INTERNATIONAL

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $PM$RACE

$PM$RACE SEC Filings

Philip Morris International Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

SEC Form 6-K filed by Ferrari N.V.

SEC Form 6-K filed by Ferrari N.V.

$PM$RACE Analyst Ratings

Ferrari downgraded by Morgan Stanley with a new price target

Ferrari upgraded by HSBC Securities with a new price target

Berenberg initiated coverage on Ferrari

$PM$RACE Insider Trading

New insider Trumpaitis Mindaugas claimed ownership of 73,002 shares (SEC Form 3)

Director Temperley Dessislava was granted 1,002 shares, increasing direct ownership by 15% to 7,756 units (SEC Form 4)

Director Bough Bonin was granted 1,002 shares, increasing direct ownership by 11% to 9,834 units (SEC Form 4)

$PM$RACE Press Releases

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

FERRARI N.V. SIGNS A NEW SYNDICATED REVOLVING CREDIT FACILITY

FERRARI RENEWS ITS PARTNERSHIP WITH PHILIP MORRIS INTERNATIONAL

$PM$RACE Leadership Updates

Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation

Philip Morris International Names New External Affairs Leader

Philip Morris International's U.S. Business Champions Female Economic Growth in Connecticut with Record-Setting $5 Million Investment Through New Partnership with Women's Business Development Council

$PM$RACE Financials

Philip Morris International Presents at 2025 Morgan Stanley Global Consumer & Retail Conference

CONSISTENT EXECUTION: STRONG Q3 2025 RESULTS

FERRARI TO ANNOUNCE THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 4

$PM$RACE Large Ownership Changes

SEC Form SC 13G/A filed by Ferrari N.V. (Amendment)

SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

Recent Analyst Ratings for
$PM
$RACE

Recent Analyst Ratings for
$PM
$RACE

$PM
$RACE
SEC Filings

$PM
$RACE
Analyst Ratings

$PM
$RACE
Insider Trading

$PM
$RACE
Press Releases

$PM
$RACE
Leadership Updates

$PM
$RACE
Financials

$PM
$RACE
Large Ownership Changes